CytomX

BMS Bails on Checkpoint Inhibitor Teaming with CytomX, Stock Sinks
BioSpace
Tue, 03/12/24 - 06:54 pm
Bristol Myers Squibb
CytomX
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Moderna caps off busy week with $1.2B CytomX collab to better target mRNA therapies
Fierce Biotech
Fri, 01/6/23 - 09:46 am
Moderna Therapeutics
MRNA
CytomX
The Cytomx paradox
EP Vantage
Mon, 07/11/22 - 10:21 am
CytomX
breast cancer
CX-2009
CytomX halts lead program and will seek a partner as breast cancer drug disappoints
Endpoints
Thu, 07/7/22 - 10:26 am
clinical trials
CytomX
breast cancer
praluzatamab ravtansine
CytomX pens $1.6B Astellas biobucks pact for T-cell R&D
Fierce Biotech
Tue, 03/24/20 - 10:22 am
Astellas
CytomX
R&D
FDA Clears IND for CytomX's CX-2029, a CD71-Directed Probody Therapeutic
CP Wire
Tue, 05/22/18 - 09:53 am
CytomX
AbbVie
CX-2029
cancer
FDA Clears IND for CytomX's CX-2029, a CD71-Directed Probody Therapeutic
Tue, 05/22/18 - 01:08 pm
CytomX
AbbVie
CX-2029
Pfizer calls it quits on CytomX deal as research comes to naught
Fierce Biotech
Thu, 03/8/18 - 11:49 pm
Pfizer
R&D
CytomX
Advancing Immuno-Oncology: The CytomX Story
PharmExec
Thu, 01/4/18 - 11:22 am
CytomX
immuno-oncology
A small drug company that's trying to make cancer treatments safer just received a $3.8 billion endorsement
Yahoo/Business Insider
Mon, 03/20/17 - 11:01 pm
CytomX
cancer immunotherapy
Bristol-Myers Squibb
AbbVie Strikes Two Cancer Collaborations: Smart Move?
Bidness, ETC
Fri, 04/22/16 - 11:05 am
AbbVie
cancer
Argenx
ARGX-115
CytomX
probodies
AbbVie and CytomX Announce Strategic Collaboration for Probody Drug Conjugates
Yahoo
Fri, 04/22/16 - 10:37 am
AbbVie
CytomX
probodies
R&D
cancer
CD71
Cancer-fighting CytomX lands $20 million Pfizer investment, makes key hires
Bizjournals.com
Tue, 01/6/15 - 08:53 am
CytomX
Pfizer
cancer
probodies
5 Private Biotechs Revolutionizing Medicine
Motley Fool
Wed, 11/13/13 - 08:58 am
Alvine Pharmaceuticals
AnaptysBio
CytomX
Parabon Nanolabs
Polyphor
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wed, 09/25/13 - 01:04 pm
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Fierce Pharma
Thu, 06/6/13 - 11:51 am
CytomX
Pfizer
antibody-drug conjugate
Private Biotechs Take Different Avenues to Rake in Cash
Seeking Alpha
Sun, 09/26/10 - 12:45 pm
Reata
Abbott Laboratories
Bardoxolone
chronic kidney disease
Asthmatx
Boston Scientific
CytomX
Emergent BioSolutions
Third Rock leads $30M round for antibody upstart CytomX
Fierce Biotech
Thu, 09/23/10 - 07:55 am
CytomX
venture capital
antibodies